Atlas Trials

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Clinical trial NCT05853718 · RECRUITING

Trial details

NCT number
NCT05853718
Sponsor
First People's Hospital of Hangzhou
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis bTenofovir Alafenamide Fumarate
Start date
2021-05-06
Primary completion
2025-12-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.